首页> 外文期刊>Breast Cancer Research >The diagnosis and management of pre-invasive breast disease: Promise of new technologies in understanding pre-invasive breast lesions
【24h】

The diagnosis and management of pre-invasive breast disease: Promise of new technologies in understanding pre-invasive breast lesions

机译:浸润前乳腺疾病的诊断和管理:了解浸润前乳腺病变的新技术的前景

获取原文
获取外文期刊封面目录资料

摘要

Array-based comparative genomic hybridization, RNA expression profiling, and proteomic analyses are new molecular technologies used to study breast cancer. Invasive breast cancers were originally evaluated because they provided ample quantities of DNA, RNA, and protein. The application of these technologies to pre-invasive breast lesions is discussed, including methods that facilitate their implementation. Data indicate that atypical ductal hyperplasia and ductal carcinoma in situ are precursor lesions molecularly similar to adjacent invasive breast cancer. It is expected that molecular technologies will identify breast tissue at risk for the development of unfavorable subtypes of invasive breast cancer and reveal strategies for targeted chemoprevention or eradication.Keywords: array comparative genomic hybridization, breast cancer, ductal carcinoma in situ, expression profiling, microarrays
机译:基于阵列的比较基因组杂交,RNA表达谱分析和蛋白质组学分析是用于研究乳腺癌的新分子技术。最初评估了浸润性乳腺癌,因为它们提供了大量的DNA,RNA和蛋白质。讨论了这些技术在浸润前乳腺病变中的应用,包括促进其实施的方法。数据表明,非典型性导管增生和原位导管癌是与邻近浸润性乳腺癌在分子上相似的前体病变。预计分子技术将鉴​​定出存在侵袭性乳腺癌亚型发展风险的乳腺组织,并揭示针对性化学预防或根除的策略。关键词:比较基因组杂交,乳腺癌,原位导管癌,表达谱,微阵列

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号